Evidence map›Paper›PMID 31240553›Full record

Trial reportInternational journal of clinical pharmacy2019

Multidisciplinary care in patients with systemic lupus erythematosus: a randomized controlled trial in China.

Le Zhang, Shikai Geng, Liping Qian, Shuang Ye, Xiaodong Wang, Guohong Lu, Yang Ding, Ting Li

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in International journal of clinical pharmacy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Le ZhangDepartment of Pharmacy, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.ORCID http://orcid.org/0000-0003-4683-5209
Shikai GengDepartment of Rheumatology, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 2000, Jiangyue RD, Shanghai, 201112, China.
Liping QianDepartment of Nursing, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shuang YeDepartment of Rheumatology, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 2000, Jiangyue RD, Shanghai, 201112, China.
Xiaodong WangDepartment of Rheumatology, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 2000, Jiangyue RD, Shanghai, 201112, China.
Guohong LuDepartment of Pharmacy, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yang DingDepartment of Mathematics, Applied Statistics, Shanghai Jiao Tong University, Shanghai, China.
Ting LiDepartment of Rheumatology, South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 2000, Jiangyue RD, Shanghai, 201112, China. leeting007@163.com.
Shanghai Jiao Tong University · CN

Funding

2018 Pujiang Outstanding Youth Project of Renji Hospital South Campus RJPJYQ2018Cooperative Research Project of Innovation of Translational Medicine from Shanghai Jiaotong University TM201807Foundation of Shanghai Municipal Commission of Health and Family Planning 20174Y0040National Natural Science Foundation cultivation project of Renji Hospital 2017PYQA08Young Scientists Fund 71804109
6 · The paper itself

Abstract

Background For the large number of systemic lupus erythematosus (SLE) patients in China, it is critical to carry out effective disease management to improve the treatment effect and reduce disease burden. A pharmacist-led multidisciplinary care model has not been reported in Chinese SLE patients before. Objective To assess the effect of patient-centered, pharmacist-led, multidisciplinary care on clinical outcomes and satisfaction with health care in Chinese SLE patients. Setting: The South Campus, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Method Participants were 143 systemic lupus erythematosus patients randomly assigned to either the intervention group (multidisciplinary care: physician, pharmacist and nurse) or the control group (usual care only). Main outcome measures The primary outcome was scores on the systemic lupus erythematosus disease activity index-2000, the satisfaction with information about medicines scale, and the EuroQol five-dimension questionnaire, assessed at baseline and 12 months. Results Between October 1, 2017 and October 1, 2018, 42 participants were included in the intervention group and 40 in the control group. At 12 months, results for the systemic lupus erythematosus disease activity index-2000 differed significantly between the intervention group and the control group (0 vs. 2, P = 0.027). Patient satisfaction with health care was also significantly greater in the intervention group than in the control group (92.9 vs. 0%, P = 0.000). According to the EuroQol five-dimension questionnaire, health quality was also improved (0.94 vs. 0.85, P = 0.006). Conclusion Our multidisciplinary care team significantly improved clinical outcomes and satisfaction with drug information in Chinese systemic lupus erythematosus patients.

Indexed as

Patient Care TeamAdultChinaFemaleHumansLupus Erythematosus, SystemicMaleMiddle AgedNursesPatient-Centered CarePatient SatisfactionPharmacistsPhysiciansQuality of Health CareSurveys and QuestionnairesTreatment OutcomeChinaPatient-centeredPharmacist-led careSatisfaction with medicines informationSystemic lupus erythematosus

Identifiers

PMID31240553
OpenAlexW2955368244

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.